Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rory L Smoot

Showing results (131-140 of 152) with videos related to

Pageof 16
Sort By:
Annals of Surgical Oncology|November 1, 2021
Neoadjuvant Chemotherapy Switch in Borderline Resectable/Locally Advanced Pancreatic CancerRoberto Alva-Ruiz, Lavanya Yohanathan, Jennifer A Yonkus, et al.
Journal of Neuroendocrinology|June 30, 2026
Outcomes of liver resections for neuroendocrine tumor liver metastases in carcinoid heart diseaseMarkus Ammann, Hallbera Gudmundsdottir, Vanja Podrascanin, et al.
JHEP Reports : Innovation in Hepatology|March 18, 2020
Biliary tract cancer patient-derived xenografts: Surgeon impact on individualized medicineJennifer L Leiting, Stephen J Murphy, John R Bergquist, et al.
Hepatology (Baltimore, Md.)|February 10, 2025
Aptamer-directed, nanovesicle-mediated targeting of undruggable molecules in preclinical cholangiocarcinoma modelsMincheng Yu, Jack W Sample, Irene K Yan, et al.
Annals of Surgical Oncology|May 4, 2026
Neoadjuvant Therapy as a Selection Strategy for Curative Resection in High-Risk Intrahepatic CholangiocarcinomaYawen Dong, Kever A Lewis, David Pereyra, et al.
Communications Biology|July 19, 2024
Diversity of post-translational modifications and cell signaling revealed by single cell and single organelle mass spectrometryDong-Gi Mun, Firdous A Bhat, Neha Joshi, et al.
Biorxiv : the Preprint Server for Biology|February 6, 2026
Multiomics-driven discovery of predictive biomarkers and strategies to overcome resistance to SFK-YAP inhibition in cholangiocarcinomaHendrien Kuipers, Danielle M Carlson, Erik Jessen, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|February 11, 2026
Redefining Upfront Resectable Pancreatic Ductal Adenocarcinoma: Should Vein Abutment Matter?Po Hong Tan, Cornelius A Thiels, Katherine Poruk, et al.
Gastro Hep Advances|August 12, 2024
Pancreatic Cancer is More Frequently Early Stage at Diagnosis in Surgically Resected Intraductal Papillary Mucinous Neoplasms With Preoperative SurveillanceJaime de la Fuente, Jacob Lui, Ryan J Lennon, et al.
JHEP Reports : Innovation in Hepatology|June 17, 2024
Metabolome-wide association identifies altered metabolites and metabolic pathways in the serum of patients with cholangiocarcinomaLinsey E Jackson, Jennifer L Tomlinson, Roberto Alva-Ruiz, et al.
Pageof 16

Showing results (131-140 of 152) with videos related to

Sort By:
Pageof 16
Annals of Surgical Oncology|November 1, 2021
Neoadjuvant Chemotherapy Switch in Borderline Resectable/Locally Advanced Pancreatic CancerRoberto Alva-Ruiz, Lavanya Yohanathan, Jennifer A Yonkus, et al.
Journal of Neuroendocrinology|June 30, 2026
Outcomes of liver resections for neuroendocrine tumor liver metastases in carcinoid heart diseaseMarkus Ammann, Hallbera Gudmundsdottir, Vanja Podrascanin, et al.
JHEP Reports : Innovation in Hepatology|March 18, 2020
Biliary tract cancer patient-derived xenografts: Surgeon impact on individualized medicineJennifer L Leiting, Stephen J Murphy, John R Bergquist, et al.
Hepatology (Baltimore, Md.)|February 10, 2025
Aptamer-directed, nanovesicle-mediated targeting of undruggable molecules in preclinical cholangiocarcinoma modelsMincheng Yu, Jack W Sample, Irene K Yan, et al.
Annals of Surgical Oncology|May 4, 2026
Neoadjuvant Therapy as a Selection Strategy for Curative Resection in High-Risk Intrahepatic CholangiocarcinomaYawen Dong, Kever A Lewis, David Pereyra, et al.
Communications Biology|July 19, 2024
Diversity of post-translational modifications and cell signaling revealed by single cell and single organelle mass spectrometryDong-Gi Mun, Firdous A Bhat, Neha Joshi, et al.
Biorxiv : the Preprint Server for Biology|February 6, 2026
Multiomics-driven discovery of predictive biomarkers and strategies to overcome resistance to SFK-YAP inhibition in cholangiocarcinomaHendrien Kuipers, Danielle M Carlson, Erik Jessen, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|February 11, 2026
Redefining Upfront Resectable Pancreatic Ductal Adenocarcinoma: Should Vein Abutment Matter?Po Hong Tan, Cornelius A Thiels, Katherine Poruk, et al.
Gastro Hep Advances|August 12, 2024
Pancreatic Cancer is More Frequently Early Stage at Diagnosis in Surgically Resected Intraductal Papillary Mucinous Neoplasms With Preoperative SurveillanceJaime de la Fuente, Jacob Lui, Ryan J Lennon, et al.
JHEP Reports : Innovation in Hepatology|June 17, 2024
Metabolome-wide association identifies altered metabolites and metabolic pathways in the serum of patients with cholangiocarcinomaLinsey E Jackson, Jennifer L Tomlinson, Roberto Alva-Ruiz, et al.
Pageof 16